INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 132 filers reported holding INTERSECT ENT INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $758,000 | -5.0% | 27,050 | -7.4% | 0.00% | 0.0% |
| Q4 2021 | $798,000 | +0.4% | 29,223 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $795,000 | +16.1% | 29,223 | -27.1% | 0.00% | 0.0% |
| Q2 2021 | $685,000 | -14.6% | 40,084 | +4.4% | 0.00% | 0.0% |
| Q1 2021 | $802,000 | +10.5% | 38,400 | +21.2% | 0.00% | 0.0% |
| Q4 2020 | $726,000 | -20.2% | 31,684 | -43.2% | 0.00% | -50.0% |
| Q3 2020 | $910,000 | -50.1% | 55,793 | -58.5% | 0.00% | -33.3% |
| Q2 2020 | $1,822,000 | +58.0% | 134,552 | +38.3% | 0.00% | +50.0% |
| Q1 2020 | $1,153,000 | +49.7% | 97,272 | +214.7% | 0.00% | +100.0% |
| Q4 2019 | $770,000 | +73.0% | 30,909 | +18.0% | 0.00% | 0.0% |
| Q3 2019 | $445,000 | -21.5% | 26,187 | +5.1% | 0.00% | 0.0% |
| Q2 2019 | $567,000 | -4.4% | 24,928 | +35.1% | 0.00% | 0.0% |
| Q1 2019 | $593,000 | +48.2% | 18,456 | +30.0% | 0.00% | – |
| Q4 2018 | $400,000 | -73.2% | 14,201 | -72.6% | 0.00% | -100.0% |
| Q3 2018 | $1,493,000 | -8.7% | 51,917 | +18.9% | 0.00% | -50.0% |
| Q2 2018 | $1,635,000 | +37.6% | 43,664 | +44.5% | 0.00% | +100.0% |
| Q1 2018 | $1,188,000 | -21.7% | 30,217 | -35.5% | 0.00% | -50.0% |
| Q4 2017 | $1,517,000 | +175.8% | 46,823 | +165.3% | 0.00% | +100.0% |
| Q3 2017 | $550,000 | +128.2% | 17,651 | +71.6% | 0.00% | – |
| Q3 2015 | $241,000 | – | 10,287 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|